Dáša Bohačiaková Group

Dr. Dasa Bohaciakova’s Neurobiology group studies Alzheimer’s disease (AD) pathogenesis in vitro using a large portfolio of neuronal stem cell-based systems, including 2D neurons and 3D cerebral organoids. We aim to study, and ultimately to understand, the mechanisms of AD initiation and potential treatment for AD. We collaborate with numerous Czech and International Laboratories, including Max Planck Institute, Germany; Aarhus University, Denmark; Amsterdam UMC, The Netherlands, and others. Our team currently consists of 5 Post-doctoral researchers, 2 Research Scientists, 2 Ph.D. students, and 2 undergrad students, who are all proficient in their fields of expertise.

We seek to complement our analytical tools with high-throughput bulk-mRNA/miRNA seq analyses as well as single-cell seq transcriptomics to fully exploit the potential of our unique model systems. As a part of the job, we offer participation in the relevant Bioinformatics training at EMBL-EBI or similar;